全州联盟内教育与标准化心脏剂量约束对接受根治性放疗的肺癌患者心脏剂量的影响
该研究分析了2012至2020年间密歇根放射肿瘤质量联盟(MROQC)27个中心1681例局部晚期非小细胞肺癌(NSCLC)根治性放疗患者,比较2012-2016年与2017-2020年实施教育与心脏剂量质量指标前后的剂量学变化。结果显示平均心脏剂量(MHD)从12.2 Gy降至10.4 Gy(P < .0001),MHD >20 Gy的患者比例从21.1%降至10.3%(P < .0001),而平均肺剂量、平均食管剂量未增加,靶区覆盖保持不变。
要点
- 全联盟教育与标准化心脏剂量约束实施后,平均心脏剂量从12.2 Gy降至10.4 Gy(P < .0001)。
- MHD >20 Gy的患者比例从21.1%降至10.3%(P < .0001)。
- 平均肺剂量和平均食管剂量未增加,靶区覆盖(D95)保持不变。
核心结论
- 在全州联盟内开展教育并实施标准化心脏剂量质量指标,与局部晚期NSCLC放疗患者平均心脏剂量降低相关。
- 上述剂量降低是在不牺牲靶区覆盖、不增加平均肺剂量、不增加平均食管剂量的情况下实现的。
研究设计与样本
- 2012年至2020年,纳入来自27个学术与社区中心的1681例接受根治性放疗的局部晚期NSCLC患者。
- 利用剂量体积直方图数据计算平均心脏剂量(MHD)、平均肺剂量和平均食管剂量,按治疗开始年份分组。
- 心脏剂量约束的教育最早在小型肺癌工作组会议中开展,随后自2016年起在全联盟范围开展;2018年实施质量指标要求MHD <20 Gy且维持靶区D95覆盖。
- 比较干预前(2012-2016年)与干预后(2017-2020年)的剂量指标,统计学分析采用Wilcoxon秩和检验。
主要发现
- 教育与心脏剂量性能指标实施后,平均MHD从干预前的12.2 Gy降至干预后的10.4 Gy(P < .0001)。
- 接受MHD >20 Gy的患者比例从21.1%降至10.3%(P < .0001)。
- 平均肺剂量和平均食管剂量未增加,靶区覆盖保持不变。
关键数值与推荐
- 2018年实施的质量指标要求平均心脏剂量(MHD)<20 Gy,同时维持靶区D95覆盖。
- 干预前(2012-2016年)平均MHD为12.2 Gy,干预后(2017-2020年)为10.4 Gy(P < .0001)。
- 干预前MHD >20 Gy的患者比例为21.1%,干预后为10.3%(P < .0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cardiac radiation exposure is associated with an increased rate of adverse cardiac events in patients receiving radiation therapy for locally advanced non-small cell lung carcinoma (NSCLC). Previous analysis of practice patterns within the Michigan Radiation Oncology Quality Consortium (MROQC) revealed 1 in 4 patients received a mean heart dose >20 Gy and significant heterogeneity existed among treatment centers in using cardiac dose constraints. The purpose of this study is to analyze the effect of education and initiation of standardized cardiac dose constraints on heart dose across a statewide consortium. METHODS AND MATERIALS: From 2012 to 2020, 1681 patients from 27 academic and community centers who received radiation therapy for locally advanced NSCLC were included in this analysis. Dosimetric endpoints including mean heart dose (MHD), mean lung dose, and mean esophagus dose were calculated using data from dose-volume histograms. These dose metrics were grouped by year of treatment initiation for all patients. Education regarding data for cardiac dose constraints first occurred in small lung cancer working group meetings and then consortium-wide starting in 2016. In 2018, a quality metric requiring mean heart dose <20 Gy while maintaining dose coverage (D95) to the target was implemented. Dose metrics were compared before (2012-2016) versus after (2017-2020) initiation of interventions targeting cardiac constraints. Statistical analysis was performed using the Wilcoxon rank sum test. RESULTS: After education and implementation of the heart dose performance metric, mean MHD declined from an average of 12.2 Gy preintervention to 10.4 Gy postintervention (P < .0001), and the percentage of patients receiving MHD >20 Gy was reduced from 21.1% to 10.3% (P < .0001). Mean lung dose and mean esophagus dose did not increase, and target coverage remained unchanged. CONCLUSIONS: Education and implementation of a standardized cardiac dose quality measure across a statewide consortium was associated with a reduction of mean heart dose in patients receiving radiation therapy for locally advanced NSCLC. These dose reductions were achieved without sacrificing target coverage, increasing mean lung dose, or increasing mean esophagus dose. Analysis of the clinical ramifications of the reduction in cardiac doses is ongoing.
引用
- Herr DJ, Hochstedler KA, Yin H, et al. Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium. Pract Radiat Oncol. 2022. PMID: 35121192. doi:10.1016/j.prro.2022.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。